Market Research Logo

XEPTAGEN SpA - Product Pipeline Analysis, 2017 Update

Summary

Xeptagen SpA (Xeptagen) is a medical device company that discovers molecular markers. The company produces diagnostic kits for the monitoring, detection, and screening of cancerous cells. It develops an optoelectronic biochip for the determination of tumor molecular markers; and conducts research on developing biochips for the simultaneous detection of biomarkers-IgM immunecomplexes. Xeptagen uses combinatorial proteomic technology to discover prognostic, predictive and early response tumor markers. The company operates through several medical device and research organizations to develop its products. It performs research for the treatment of liver cancer, colorectal cancer, and prostate cancer. Xeptagen is headquartered in Marghera, Italy.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company XEPTAGEN SpA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


XEPTAGEN SpA Company Overview
XEPTAGEN SpA Company Snapshot
XEPTAGEN SpA Pipeline Products and Ongoing Clinical Trials Overview
XEPTAGEN SpA – Pipeline Analysis Overview
XEPTAGEN SpA - Key Facts
XEPTAGEN SpA - Major Products and Services
XEPTAGEN SpA Pipeline Products by Development Stage
XEPTAGEN SpA Pipeline Products Overview
CA15.3 - IgM Kit
CA15.3 - IgM Kit Product Overview
CA19.9 - IgM Kit
CA19.9 - IgM Kit Product Overview
CEA - IgM Kit - Breast Cancer
CEA - IgM Kit - Breast Cancer Product Overview
compleXima CRC Biochip - Colon Cancer
compleXima CRC Biochip - Colon Cancer Product Overview
compleXima HCC Biochip - Liver Cancer
compleXima HCC Biochip - Liver Cancer Product Overview
compleXima Polycancer Biochip
compleXima Polycancer Biochip Product Overview
DCP-IgM Kit - Liver Cancer
DCP-IgM Kit - Liver Cancer Product Overview
GPC3-IgM Kit - Liver Cancer
GPC3-IgM Kit - Liver Cancer Product Overview
Osteopontin-IgM Kit - Liver Cancer
Osteopontin-IgM Kit - Liver Cancer Product Overview
SCCA - IgM Kit - Cervical Cancer
SCCA - IgM Kit - Cervical Cancer Product Overview
SCCA - IgM Kit - Esophageal Cancer
SCCA - IgM Kit - Esophageal Cancer Product Overview
SCCA - IgM Kit - NASH
SCCA - IgM Kit - NASH Product Overview
SCCA - IgM Kit Scleroderma
SCCA - IgM Kit Scleroderma Product Overview
Survivin-IgM Kit - Liver Cancer
Survivin-IgM Kit - Liver Cancer Product Overview
VEGF - IgM Kit - Pulmonary Cancer
VEGF - IgM Kit - Pulmonary Cancer Product Overview
VEGF-IgM Kit - Liver Cancer
VEGF-IgM Kit - Liver Cancer Product Overview
XEPTAGEN SpA - Key Competitors
XEPTAGEN SpA - Key Employees
XEPTAGEN SpA - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
XEPTAGEN SpA Pipeline Products and Ongoing Clinical Trials Overview
XEPTAGEN SpA Pipeline Products by Equipment Type
XEPTAGEN SpA Pipeline Products by Indication
XEPTAGEN SpA, Key Facts
XEPTAGEN SpA, Major Products and Services
XEPTAGEN SpA Number of Pipeline Products by Development Stage
XEPTAGEN SpA Pipeline Products Summary by Development Stage
CA15.3 - IgM Kit - Product Status
CA15.3 - IgM Kit - Product Description
CA19.9 - IgM Kit - Product Status
CA19.9 - IgM Kit - Product Description
CEA - IgM Kit - Breast Cancer - Product Status
CEA - IgM Kit - Breast Cancer - Product Description
compleXima CRC Biochip - Colon Cancer - Product Status
compleXima CRC Biochip - Colon Cancer - Product Description
compleXima HCC Biochip - Liver Cancer - Product Status
compleXima HCC Biochip - Liver Cancer - Product Description
compleXima Polycancer Biochip - Product Status
compleXima Polycancer Biochip - Product Description
DCP-IgM Kit - Liver Cancer - Product Status
DCP-IgM Kit - Liver Cancer - Product Description
GPC3-IgM Kit - Liver Cancer - Product Status
GPC3-IgM Kit - Liver Cancer - Product Description
Osteopontin-IgM Kit - Liver Cancer - Product Status
Osteopontin-IgM Kit - Liver Cancer - Product Description
SCCA - IgM Kit - Cervical Cancer - Product Status
SCCA - IgM Kit - Cervical Cancer - Product Description
SCCA - IgM Kit - Esophageal Cancer - Product Status
SCCA - IgM Kit - Esophageal Cancer - Product Description
SCCA - IgM Kit - NASH - Product Status
SCCA - IgM Kit - NASH - Product Description
SCCA - IgM Kit Scleroderma - Product Status
SCCA - IgM Kit Scleroderma - Product Description
Survivin-IgM Kit - Liver Cancer - Product Status
Survivin-IgM Kit - Liver Cancer - Product Description
VEGF - IgM Kit - Pulmonary Cancer - Product Status
VEGF - IgM Kit - Pulmonary Cancer - Product Description
VEGF-IgM Kit - Liver Cancer - Product Status
VEGF-IgM Kit - Liver Cancer - Product Description
XEPTAGEN SpA, Key Employees
Glossary
List of Figures
XEPTAGEN SpA Pipeline Products by Equipment Type
XEPTAGEN SpA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report